Filter Results:
(5,021)
Show Results For
- All HBS Web
(5,021)
- People (17)
- News (1,090)
- Research (3,235)
- Events (21)
- Multimedia (35)
- Faculty Publications (2,006)
Show Results For
- All HBS Web
(5,021)
- People (17)
- News (1,090)
- Research (3,235)
- Events (21)
- Multimedia (35)
- Faculty Publications (2,006)
- April 2008
- Supplement
ProfitLogic (CW)
By: Lynda M. Applegate, Richard G. Hamermesh and Michael J. Roberts
This interactive spreadsheet accompanies the ProfitLogic case (#802-110) to enable analysis of the cash flow implications of three business models that the company is considering. Students are able to change key assumptions and see the impact on cash flow. View Details
- August 2019
- Case
Humanistic Capitalism at Brunello Cucinelli
By: Francesca Gino and Gary Pisano
This case explores one company’s attempt to experiment with a different underlying model for a capitalist enterprise. Brunello Cucinelli, S.p.A. is a leading manufacturer of luxury fashion apparel. Despite being a publicly traded enterprise with annual revenues... View Details
Keywords: Corporate Culture; Human Resource Practices; Growth; Growth Strategy; Motivation; Values; Fashion; Capitalism; Organizational Culture; Values and Beliefs; Human Resources; Management; Business Model; Policy; Behavior; Growth and Development Strategy; Luxury; Italy
Gino, Francesca, and Gary Pisano. "Humanistic Capitalism at Brunello Cucinelli." Harvard Business School Case 920-007, August 2019.
- January 2021
- Case
mPharma (A)
By: Rembrand Koning, John D. Macomber, Pippa Tubman Armerding and Wale Lawal
mPharma pioneered electronic prescriptions in Ghana, and aimed to increase drug affordability and accessibility in Africa, but the company remained unprofitable. Following investor concerns about mPharma's business, CEO Gregory Rockson considered alternative business... View Details
Keywords: Strategy; Entrepreneurship; Acquisition; Health; Business Model; Health Industry; Technology Industry; Ghana
Koning, Rembrand, John D. Macomber, Pippa Tubman Armerding, and Wale Lawal. "mPharma (A)." Harvard Business School Case 721-428, January 2021.
- November 1997 (Revised May 1999)
- Case
Medical Foods, Inc.
By: Ray A. Goldberg and Tom Clay
Dr. Franklin Lowe is CEO of a new kind of company in a new kind of industry--medical foods. He must select a business model and partners that will help make this a viable business. View Details
Keywords: Business Model; Partners and Partnerships; Business or Company Management; Strategy; Business Startups; Health Care and Treatment; Food; Innovation and Management; Food and Beverage Industry; Health Industry
Goldberg, Ray A., and Tom Clay. "Medical Foods, Inc." Harvard Business School Case 598-048, November 1997. (Revised May 1999.)
- March 2002 (Revised May 2002)
- Case
Genzyme: Engineering the Market for Orphan Drugs
Genzyme has made money with external technology in orphan drug markets generally considered to be too small to be attractive to other drug companies. Now competition is entering these same markets, placing Genzyme's business model under new pressures. View Details
Keywords: Business Model; Information Technology; Market Entry and Exit; Biotechnology Industry; Pharmaceutical Industry
Chesbrough, Henry W., and Clarissa Ceruti. "Genzyme: Engineering the Market for Orphan Drugs." Harvard Business School Case 602-147, March 2002. (Revised May 2002.)
- 2010
- Article
Competing against Online Sharing
By: Ramon Casadesus-Masanell and Andres Hervas-Drane
This paper aims to explore online sharing of copyrighted content over peer-to-peer (p2p) file sharing networks and its impact on the music industry and to assess the viable business models for the industry in the future. View Details
Keywords: Consumers; Computer Networks; Resource Sharing; Online Operations; Internet and the Web; Copyright; Networks; Business Model; Music Industry
Casadesus-Masanell, Ramon, and Andres Hervas-Drane. "Competing against Online Sharing." Management Decision 48, no. 8 (2010): 1247–1260.
- March 2009 (Revised January 2010)
- Background Note
The Newspaper Industry in Crisis
By: David J. Collis, Peter W. Olson and Mary Furey
This note is a primer on the newspaper industry, which has been in decline in the U.S. and Western Europe. The 19th century business model whereby news and editorial content was packaged and delivered to homes daily and paid for by national advertisers has been... View Details
Keywords: Business Model; Business History; Newspapers; Disruptive Innovation; Consumer Behavior; Business Strategy; Internet; Journalism and News Industry; Publishing Industry; Europe; United States
Collis, David J., Peter W. Olson, and Mary Furey. "The Newspaper Industry in Crisis." Harvard Business School Background Note 709-463, March 2009. (Revised January 2010.)
- July 2001 (Revised August 2005)
- Case
Medicines Company, The
It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The... View Details
Keywords: Business Model; Change Management; Decision Choices and Conditions; Cost Management; Price; Product Marketing; Product Launch; Product Development; Risk and Uncertainty; Health Industry; Pharmaceutical Industry
Gourville, John T. "Medicines Company, The." Harvard Business School Case 502-006, July 2001. (Revised August 2005.)
- July 2007 (Revised February 2010)
- Case
Launching Telmore (A)
By: Ramon Casadesus-Masanell, Celso Fernandez and Moritz Jobke
When the Danish mobile phone service provider Telmore entered the market in October 2000, few people took notice. Its business model was not perceived as particularly aggressive or threatening to the industry. Less than three years later, Telmore's creative adaptation... View Details
Keywords: Business Model; Disruptive Innovation; Market Entry and Exit; Creativity; Adaptation; Competitive Advantage; Telecommunications Industry; Denmark
Casadesus-Masanell, Ramon, Celso Fernandez, and Moritz Jobke. "Launching Telmore (A)." Harvard Business School Case 708-414, July 2007. (Revised February 2010.)
- August 2019 (Revised March 2022)
- Case
Lemonade: Disrupting Insurance with Instant Everything, Killer Prices, and a Big Heart
By: Elie Ofek and Danielle Golan
Launching its first products in the fall of 2016 in New York, insurtech startup Lemonade was on a mission to disrupt the insurance market by using AI and behavioral economics principles. The company offered renters, homeowners, and condo insurance and mainly targeted... View Details
Keywords: AI; Business Startups; Insurance; Technological Innovation; Business Model; Disruption; Brands and Branding; Growth and Development Strategy; Global Strategy; Decision Making; Insurance Industry; Technology Industry
Ofek, Elie, and Danielle Golan. "Lemonade: Disrupting Insurance with Instant Everything, Killer Prices, and a Big Heart." Harvard Business School Case 520-020, August 2019. (Revised March 2022.)
- September 2023
- Case
DocSend: A Path off the Plateau?
By: Thomas R. Eisenmann and Jeffrey Huizinga
Recounts how the leaders of DocSend, an early-stage startup that offered tools for sharing files online, searched for a viable business model and weighed tradeoffs in transitioning from a sales-led to a product-led "go-to-market" approach. View Details
Keywords: Technology; Start-up; Growth; Business Model; Business Startups; Sales; Growth and Development Strategy; Technology Industry
Eisenmann, Thomas R., and Jeffrey Huizinga. "DocSend: A Path off the Plateau?" Harvard Business School Case 824-038, September 2023.
- January 2025
- Supplement
Hippo: Weathering the Storm of the Home Insurance Crisis (B)
By: Lauren Cohen, Grace Headinger and Sophia Pan
Rick McCathron, CEO of Hippo, was optimistic about the InsurTech's path to profitability after navigating the financial uncertainties of 2022. By bundling their home insurance services with third-parties and established insurance incumbents, Hippo was adopting a... View Details
Keywords: Fintech; Underwriters; Big Data; Homeowners' Insurance; Catastrophe Risk; Global Warming; Environment; Business Economics; Vertical Specialization; Bundling; Economies Of Scale; Business Model; Forecasting and Prediction; Climate Change; Environmental Sustainability; Green Technology; Technological Innovation; Natural Environment; Natural Disasters; Weather; Business Strategy; Competitive Advantage; Business Earnings; Insurance; Social Issues; Profit; Growth and Development Strategy; Insurance Industry; California; United States
- 2009
- Working Paper
Technology Innovation and Diffusion as Sources of Output and Asset Price Fluctuations
By: Diego A. Comin, Mark Gertler and Ana Maria Santacreu
We develop a model in which innovations in an economy's growth potential are an important driving force of the business cycle. The framework shares the emphasis of the recent "new shock" literature on revisions of beliefs about the future as a source of fluctuations,... View Details
Keywords: Business Cycles; Economic Growth; Asset Pricing; Technological Innovation; Mathematical Methods; System Shocks; Technology Adoption
Comin, Diego A., Mark Gertler, and Ana Maria Santacreu. "Technology Innovation and Diffusion as Sources of Output and Asset Price Fluctuations." Harvard Business School Working Paper, No. 09-134, May 2009. (Revise and Resubmit at the Journal of Political Economy.)
- June 1997 (Revised March 2001)
- Case
Genset Initial Public Offering (A)
By: Paul A. Gompers and Jeffrey M. Anapolsky
Pascal Brandys, founder and CEO of Genset, must decide whether to take this young biotechnology company public. If so, should he do a dual offering in both France and the U.S.? The case also explores the business models in genomics research. View Details
Keywords: Business Model; Initial Public Offering; Genetics; Going Public; Management Teams; Biotechnology Industry; France; United States
Gompers, Paul A., and Jeffrey M. Anapolsky. "Genset Initial Public Offering (A)." Harvard Business School Case 297-096, June 1997. (Revised March 2001.)
Strategies to Fight Ad-sponsored Rivals
We analyze the optimal strategy of a high-quality incumbent that faces a low-quality ad-sponsored competitor. In addition to competing through adjustments of tactical variables such as price or the number of ads a product carries, we allow the incumbent to... View Details
- 01 Nov 2019
- Video
James Mwangi
James Mwangi, CEO and Managing Director of CBS Group and Equity Group Holdings, discusses innovation in microfinance business models in Kenya.
View Details- January–February 2015
- Article
The Truth about CSR
By: Kasturi Rangan, Lisa Chase and Sohel Karim
The article discusses corporate social responsibility (CSR) programs. In the authors' view many of these programs consist of disparate, uncoordinated initiatives that fail to maximize their impact. They recommend a more coherent strategy that divides CSR efforts into... View Details
Rangan, Kasturi, Lisa Chase, and Sohel Karim. "The Truth about CSR." Harvard Business Review 93, nos. 1/2 (January–February 2015): 40–49.
- June 2008
- Case
Starbucks Coffee Company in the 21st Century
By: Nancy F. Koehn, Marya Lisl Hill-Popper Besharov and Katherine Miller
The case explores the opportunities and challenges confronting Starbucks in the early 21st century. For more than 15 years, Starbucks has grown swiftly and successfully, helping create a large, dynamic market for specialty coffee, building one of the world's most... View Details
Keywords: Business Model; Economy; Growth Management; Brands and Branding; Corporate Social Responsibility and Impact; Competition
Koehn, Nancy F., Marya Lisl Hill-Popper Besharov, and Katherine Miller. "Starbucks Coffee Company in the 21st Century." Harvard Business School Case 808-019, June 2008.